logo transparent gif
top_left_edge top_white_spacer top_right_edge
Home Latest Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Forex Investor Insights Investment News Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock

Cordlife Share Price Plummet on Suspension over Storage Fiasco

This article is republished with permission from Tip Ranks .

01-Dec-2023    Share!

SGX-listed cord banking company Cordlife Group Limited (SG:P8A) shares experienced a sharp fall over its storage fiasco, leading to a 6-month suspension of its services. The Ministry of Health (MOH) in Singapore discovered that Cordlife's 22 storage tanks were not correctly maintaining temperatures, compromising the samples.

This led to damaged cord-blood units for more than 2,000 customers, which cannot be further used for any stem cell transplant purpose.

Cordlife operates a leading stem cell banking network in Asia, catering to over six lakh customers. The company collects cord blood samples through its blood banks and stores them at ideal temperatures for potential stem cell transplants in the future.

As per the ministry’s statement, the company is suspended from collecting, testing, processing, and storing new cord blood or tissue samples for a duration of six months. The suspension is set to commence within two weeks of the notice.

Following the news, the Cordlife share price crashed by 31% today. The stock went down by almost 40% during the midday trading sessions.

Tougher Times Ahead

MOH stated that further investigations are currently in progress, and it has granted Cordlife a 14-day period to submit written statements. Currently, MOH is investigating the remaining six storage tanks, which hold over 17,000 blood units. MOH also mentioned that the company could face financial penalties or legal action in the future.

The news has sparked frustration among customers, who have completely lost trust in the company. On the other hand, the company stated that it is currently engaged in a comprehensive investigation to understand the situation. The company has appealed for clients’ patience during this process. It has also assured its clients that it will put forth full efforts to find a replacement for the cord blood samples.

The company has appealed for clients’ patience during this process.


Contributed By: Tip Ranks

ShareJunction Version: 22 Oct 2017 - All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux. Hosted with Signetique Cloud.